ATL loses appeal on SRI lawsuit

Article

ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a

ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a close. The company has already set aside $37.1 million in prior financial periods to cover the full cost of the judgment, which was awarded in 1996 (SCAN 6/5/96). SRI filed the suit in 1991, charging ATL with violating a patent SRI received in 1977 for tracking filter circuits used in ATL's Ultramark 4, Ultramark 5, and ADR 4000 ultrasound scanners, all of which have been discontinued. The relevant patent expired in 1994, according to ATL.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.